SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk (SNDK) is facing severe volatility and a sharp selloff driven by broader semiconductor industry pressure, particularly triggered by disappointing earnings from South Korean chipmakers like SK Hynix and ongoing concerns regarding competitive threats from Chinese memory manufacturers. Community discourse is highly polarized, with many investors debating whether this is a fundamental collapse or a manipulative overreaction by algorithmic traders, leading to intense frustration among retail holders regarding the stock's rapid decline from its earlier highs.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is seeing extreme volatility as the broader memory sector reacts to an earnings miss from South Korean competitor SK Hynix, triggering a ripple effect across chip stocks. The community is sharply divided between those viewing the pullback as a manipulated shakeout of retail investors by market makers and those fearing the start of a deeper cyclical downturn in AI-related hardware demand.

SK hynix, Inc. engages in the design, manufacture, and sale of semiconductor products. Its products include dynamic random access memory, not-AND flash memory, and multi-chip package. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is experiencing extreme volatility following a quarterly earnings report that showed record-breaking growth but missed aggressive analyst estimates, sparking intense debate over whether the sell-off is a result of valuation concerns or institutional manipulation. The community is deeply divided, with many traders frustrated by the stock's impact on the broader semiconductor sector and local market instability, while others maintain that the underlying fundamentals remain strong for long-term AI-driven demand.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing intense selling pressure, with the community actively debating whether this is a structural washout driven by extreme leveraged unwinding and concerns over semiconductor capex or a temporary panic-driven bear trap. Sentiment is deeply polarized between traders attempting to bottom-fish the volatility and those expecting further downside as they weigh broader sector concerns against the potential for a relief rally around upcoming earnings.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is currently experiencing high volatility driven by a broader semiconductor selloff and intense investor debate over whether the massive capital expenditure fueling AI infrastructure will generate sustainable long-term returns. While some in the community are panic-selling and calling for further corrections, others are actively treating the pullback as a buying opportunity, pointing to recent partnerships and sustained demand for AI-compute capacity as evidence that the company's growth story remains intact.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently facing a sharp sell-off driven by broader semiconductor sector volatility, fears over AI spending sustainability, and concerns regarding rising competition from China. While some investors are alarmed by technical breakdowns and negative sentiment, others remain focused on the company's long-term potential as a critical U.S. foundry and domestic manufacturer.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is experiencing high volatility and intense community debate as investors brace for the upcoming earnings report, with sentiment split between long-term confidence in the company's fundamentals and frustration over stagnant price action. Market participants are actively monitoring potential catalysts like guidance updates and macro-economic factors, while the community remains divided on whether this is a prime accumulation opportunity or a signal for further downside.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is facing intense downward pressure driven by a broader sector-wide sell-off in AI infrastructure and data center stocks, leading to heavy speculation about institutional manipulation and forced liquidations. Despite the technical volatility and debate over valuation, the community remains sharply divided between those bracing for further downside and long-term investors using the dip to accumulate shares ahead of upcoming earnings.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is facing intense volatility after FDA briefing documents cast doubt on the trial's statistical validity, triggering a sharp decline in the share price ahead of an upcoming Advisory Committee meeting. The community is sharply divided, with bulls arguing the data demonstrates durable efficacy in treating Duchenne muscular dystrophy and suggesting the FDA's critique relies on obsolete analysis, while bears point to the potential for regulatory rejection due to the cited statistical discrepancies.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Invesco QQQ Trust is trending amid significant volatility driven by semiconductor sector weakness following poor earnings in South Korea, alongside rising geopolitical tensions and uncertainty ahead of key central bank policy decisions. The community is actively debating the sustainability of AI-related growth and whether the recent price swings signal a deeper technical correction or a temporary pullback within a broader uptrend.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Friday's ETF Movers: XBI, BOTZ

In trading on Friday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 1.5% on the day. Components of that ETF showing particular strength include shares of Sellas Life Sciences Group, up about 11.2% and shares of Sionna Therapeutics, up about 10.4% on the day...

Wedbush Initiates Coverage of Sionna Therapeutics (SION)

Wedbush Initiates Coverage of Sionna Therapeutics (SION...

Sionna Therapeutics (NASDAQ:SION) Upgraded to "Strong-Buy" at Wedbush

Wedbush raised Sionna Therapeutics to a "strong-buy" rating in a report on Monday...

Sionna Therapeutics, Inc. $SION Shares Acquired by Jennison Associates LLC

Jennison Associates LLC increased its stake in Sionna Therapeutics, Inc. (NASDAQ:SION - Free Report) by 11.8% in the fourth quarter, according to its most recent 13F filing with the Securities...

JonesTrading Forecasts Strong Price Appreciation for Sionna Therapeutics (NASDAQ:SION) Stock

JonesTrading boosted their target price on Sionna Therapeutics from $52.00 to $63.00 and gave the stock a "buy" rating in a research report on Tuesday...

Sionna Insider Sells $2.5 Million in Stock Amid 215% Surge, but Here's What Investors Should Watch

Key PointsA director of Sionna Therapeutics reported the sale of 55,345 shares for a total transaction value of $2.47 million, using a weighted average price of $44.67 per share across April 17-18, 2026...

Sionna Therapeutics (NASDAQ:SION) Earns "Buy" Rating from BTIG Research

BTIG Research reissued a "buy" rating and set a $58.00 price target on shares of Sionna Therapeutics in a report on Monday...

Sionna Therapeutics (NASDAQ:SION) Stock Price Up 6.7% - Here's What Happened

Sionna Therapeutics (NASDAQ:SION) Stock Price Up 6.7% - Still a Buy...

Sionna Therapeutics (NASDAQ:SION) Stock Price Down 11.3% - What's Next?

Sionna Therapeutics (NASDAQ:SION) Shares Down 11.3% - Here's What Happened...

Sionna Therapeutics (NASDAQ:SION) Director Orbimed Advisors Llc Sells 52,397 Shares

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) Director Orbimed Advisors Llc sold 52,397 shares of the firm's stock in a transaction on Friday, April 17th. The shares were sold at an average price of $44.68, for a total value of $2,341,097.96. Following the transaction, the director...

Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.

Sionna Therapeutics Inc.

Sionna Short Squeeze Fades As Raymond James Backs Cystic Fibrosis Breakthrough, RBC Warns Treatments Set High Bar

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

SIONSionna Therapeutics Inc

Latest SION News